Health Care & Life Sciences » Pharmaceuticals | Targeted Medical Pharma Inc.

Targeted Medical Pharma Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
Sales/Revenue
8,809.70
7,296.40
9,555.60
7,112.40
5,260.90
Cost of Goods Sold (COGS) incl. D&A
2,860.00
3,295.00
3,196.80
2,422.40
2,215.80
Gross Income
5,949.70
4,001.40
6,358.80
4,690.00
3,045.10
SG&A Expense
11,730.20
10,141.20
10,199.70
7,300.90
5,074.90
EBIT
5,780.50
6,139.80
3,841.00
2,611.00
2,029.80
Unusual Expense
-
4,432.70
159.30
11.10
136.10
Interest Expense
875.80
2,199.60
-
1,229.30
1,173.60
Pretax Income
6,648.70
12,772.10
3,670.70
3,829.20
3,067.20
Income Tax
2,471.60
3,185.90
5,666.90
65.80
-
Consolidated Net Income
4,177.10
9,586.20
9,337.60
3,895.00
3,067.20
Net Income
4,177.10
9,586.20
9,337.60
3,895.00
3,043.80
Net Income After Extraordinaries
4,177.10
9,586.20
9,337.60
3,895.00
3,043.80
Net Income Available to Common
4,177.10
9,586.20
9,337.60
3,895.00
3,043.80
EPS (Basic)
0.16
0.43
0.39
0.15
0.11
Basic Shares Outstanding
25,723.40
22,154.70
23,828.70
26,385.50
27,218.00
EPS (Diluted)
0.16
0.43
0.39
0.15
0.11
Diluted Shares Outstanding
25,723.40
22,154.70
23,828.70
26,385.50
27,218.00
EBITDA
5,322.70
5,704.00
3,429.10
2,209.10
1,799.10
Non-Operating Interest Income
7.60
-
10.90
-
-
Minority Interest Expense
-
-
-
-
23.40

About Targeted Medical Pharma

View Profile
Address
2980 Beverly Glen Circle
Los Angeles California 90077
United States
Employees -
Website http://www.tmedpharma.com
Updated 07/08/2019
Targeted Medical Pharma, Inc. engages in the research, development, and commercialization of amino acid based medications. It operates through the following segments: Targeted Medical Pharma ("TMP"); Complete Claims Processing, Inc. ("CCPI"); and Amino Nutritionals. The TMP segment offers physician therapeutics, medical foods, and generic medicines.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.